EMD 281014, a new selective serotonin 5-HT2A receptor antagonist-Reference-Cited by-同舟云学术

EMD 281014, a new selective serotonin 5-HT2A receptor antagonist

Published:2003-07 Issue:2-3 Volume:473 Page:229-230
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Bartoszyk Gerd D.,van Amsterdam Christoph,Böttcher Henning,Seyfried Christoph A.

Publisher

Elsevier BV

Subject

Pharmacology

Reference9 articles.

1. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors;Bonhaus;Br. J. Pharmacol.,1995

2. Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI;Darmani;Pharmacol. Biochem. Behav.,1995

3. 5-HT2A antagonists in psychiatric disorders;De Angelis;Curr. Opin. Investig. Drugs,2002

4. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT2C/2B receptor antagonists: neurochemical and behavioural studies;Hutson;Neuropharmacology,2000

5. Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile;Kehne;J. Pharmacol. Exp. Ther.,1996

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset;Pharmacological Reports;2022-06-27

2. An ontogenic study of receptor mechanisms by which acute administration of low-doses of methamphetamine suppresses DOI-induced 5-HT2A-receptor mediated head-twitch response in mice;BMC Neuroscience;2022-01-04

3. Additive effects of mGluR2 positive allosteric modulation, mGluR2 orthosteric stimulation and 5-HT2AR antagonism on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset;Naunyn-Schmiedeberg's Archives of Pharmacology;2021-09-22

4. Drug Discovery in Erectile Dysfunction and Sleep Disorders;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

5. Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease;Neuropharmacology;2021-03